BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2014 6:22:00 PM | Browse: 1299 | Download: 1416
Publication Name World Journal of Clinical Cases
Manuscript ID 3460
Country Italy
ISSN 2307-8960 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Long lasting response to second-line everolimus in kidney cancer
Manuscript Source Invited Manuscript
All Author List Antonella Virtuoso, Tania Policastro, Michela Izzo, Piera Federico, Carlo Buonerba, Pasquale Rescigno and Giuseppe Di Lorenzo
Funding Agency and Grant Number
Corresponding Author Giuseppe Di Lorenzo, MD, PhD, Deparment of Clinical Medicine, University Federico Ⅱ of Naples, Via Pansini, 5, 80131 Naples, Italy. giuseppedilorenzoncol@hotmail.com
Key Words Metastatic renal cell carcinoma; Everolimus (RAD001); Sunitinib; Progression-free survival
Core Tip Everolimus (RAD001) is an orally administered inhibitor of the mammalian target of rapamycin pathway. Everolimus is recommended for the second line therapy of metastatic renal cell carcinoma after a Tyrosine kinase inhibitor. In the case presented here, everolimus was administered after first line therapy with sunitinib. The prolonged progression-free survival (PFS) obtained with everolimus in this case is of peculiar interest, as it is a multiple of the median PFS obtained in with everolimus in the regulatory trial.
Publish Date 2013-08-07 10:29
Citation Virtuoso A, Policastro T, Izzo M, Federico P, Buonerba C, Rescigno P, Di Lorenzo G. Long lasting response to second-line everolimus in kidney cancer. World J Clin Cases 2013; 1(5): 166-168
URL http://www.wjgnet.com/2307-8960/full/v1/i5/166.htm
DOI http://dx.doi.org/10.12998/wjcc.v1.i5.166
Full Article (PDF) WJCC-1-166.pdf